Shareholders Equity: The sum of preferred and common equity items.
Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Shareholders Equity of $37.56M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$201.96M |
|
$148.96M |
|
$181.58M |
|
$358.64M |
|
$159.82M |
|
$121.85M |
|
$161.25M |
|
$321.08M |
|
$37.56M |
|
$23.77M |
|
|
Shareholders Equity |
$37.56M |
-- |
|
| Cash Flow Statement Financials | |
$-15.26M |
|
$-49.60M |
|
$43.12M |
|
$142.21M |
|
$122.35M |
|
$-19.86M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|